|
Volumn 49, Issue 6, 2017, Pages 782-783
|
Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFTOLOZANE PLUS TAZOBACTAM;
CREATININE;
HYPERTENSIVE FACTOR;
ANTIINFECTIVE AGENT;
BETA LACTAMASE INHIBITOR;
CEFTOLOZANE, TAZOBACTAM DRUG COMBINATION;
CEPHALOSPORIN DERIVATIVE;
TAZOBACTAM;
ABDOMINAL INFECTION;
ADULT;
ANTIBIOTIC SENSITIVITY;
ARTIFICIAL VENTILATION;
BLOOD VESSEL GRAFT;
BONE INFECTION;
CENTRAL NERVOUS SYSTEM INFECTION;
CHILD;
CLINICAL ARTICLE;
CREATININE CLEARANCE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
EXTENSIVELY DRUG RESISTANT PSEUDOMONAS INFECTION;
GRAFT INFECTION;
GRAFT RECIPIENT;
HOSPITAL MORTALITY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTIOUS ARTHRITIS;
INTENSIVE CARE UNIT;
LENGTH OF STAY;
LETTER;
ORGAN TRANSPLANTATION;
OUTCOME ASSESSMENT;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTION;
RESPIRATORY TRACT INFECTION;
RETROSPECTIVE STUDY;
SALVAGE THERAPY;
SEPTIC SHOCK;
SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;
TREATMENT DURATION;
URINARY TRACT INFECTION;
VENTILATOR ASSOCIATED PNEUMONIA;
ADVERSE DRUG REACTION;
AGED;
DRUG EFFECT;
FEMALE;
ISOLATION AND PURIFICATION;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
MULTIDRUG RESISTANCE;
PATHOLOGY;
PROCEDURES;
TREATMENT OUTCOME;
YOUNG ADULT;
ADULT;
AGED;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMASE INHIBITORS;
CEPHALOSPORINS;
CHILD, PRESCHOOL;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
SALVAGE THERAPY;
TAZOBACTAM;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 85018867531
PISSN: 09248579
EISSN: 18727913
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2017.04.001 Document Type: Letter |
Times cited : (41)
|
References (5)
|